197 related articles for article (PubMed ID: 33791912)
1. Clinical Characteristics of BRAF V600E Gene Mutation in Patients of Epilepsy-Associated Brain Tumor: a Meta-analysis.
Xing H; Song Y; Zhang Z; Koch PD
J Mol Neurosci; 2021 Sep; 71(9):1815-1824. PubMed ID: 33791912
[TBL] [Abstract][Full Text] [Related]
2. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma.
Schindler G; Capper D; Meyer J; Janzarik W; Omran H; Herold-Mende C; Schmieder K; Wesseling P; Mawrin C; Hasselblatt M; Louis DN; Korshunov A; Pfister S; Hartmann C; Paulus W; Reifenberger G; von Deimling A
Acta Neuropathol; 2011 Mar; 121(3):397-405. PubMed ID: 21274720
[TBL] [Abstract][Full Text] [Related]
3. [BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy].
Qi XL; Yao K; Duan ZJ; Bian Y; Ma Z; Piao YS; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):664-670. PubMed ID: 30220118
[No Abstract] [Full Text] [Related]
4. BRAF V600E mutation in epilepsy-associated glioneuronal tumors: Prevalence and correlation with clinical features in a Chinese population.
Zhang YX; Shen CH; Guo Y; Zheng Y; Zhu JM; Ding Y; Tang YL; Wang S; Ding MP
Seizure; 2017 Feb; 45():102-106. PubMed ID: 27984807
[TBL] [Abstract][Full Text] [Related]
5. Integrated genotype-phenotype analysis of long-term epilepsy-associated ganglioglioma.
Wang Y; Wang L; Blümcke I; Zhang W; Fu Y; Shan Y; Piao Y; Zhao G
Brain Pathol; 2022 Jan; 32(1):e13011. PubMed ID: 34355449
[TBL] [Abstract][Full Text] [Related]
6. BRAF V600E mutation in neocortical posterior temporal epileptogenic gangliogliomas.
Martinoni M; Marucci G; de Biase D; Rubboli G; Volpi L; Riguzzi P; Marliani F; Toni F; Naldi I; Bisulli F; Tinuper P; Michelucci R; Baruzzi A; Tallini G; Giulioni M
J Clin Neurosci; 2015 Aug; 22(8):1250-3. PubMed ID: 25937573
[TBL] [Abstract][Full Text] [Related]
7. Autophagy-related protein expression was associated with BRAF V600E mutation in epilepsy associated glioneuronal tumors.
Shen CH; Zhang YX; Xu JH; Zhu QB; Zhu JM; Guo Y; Ding Y; Wang S; Ding MP
Epilepsy Res; 2017 Sep; 135():123-130. PubMed ID: 28667867
[TBL] [Abstract][Full Text] [Related]
8. Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma.
Pagès M; Beccaria K; Boddaert N; Saffroy R; Besnard A; Castel D; Fina F; Barets D; Barret E; Lacroix L; Bielle F; Andreiuolo F; Tauziède-Espariat A; Figarella-Branger D; Puget S; Grill J; Chrétien F; Varlet P
Brain Pathol; 2018 Jan; 28(1):103-111. PubMed ID: 27984673
[TBL] [Abstract][Full Text] [Related]
9. Epilepsy Outcome and Pathology Analysis for Ganglioglioma: A Series of 51 Pediatric Patients.
Liu Q; Cai L; Sun Y; Wang Y; Yu H; Liu C; Wang H; Zhang S; Gong J
Pediatr Neurol; 2023 Dec; 149():127-133. PubMed ID: 37879136
[TBL] [Abstract][Full Text] [Related]
10. BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumors.
Koh HY; Kim SH; Jang J; Kim H; Han S; Lim JS; Son G; Choi J; Park BO; Heo WD; Han J; Lee HJ; Lee D; Kang HC; Shong M; Paik SB; Kim DS; Lee JH
Nat Med; 2018 Nov; 24(11):1662-1668. PubMed ID: 30224756
[TBL] [Abstract][Full Text] [Related]
11. The clinical and pathological features of low-grade epilepsy-associated glioneuronal tumors.
Xie M; Wang X; Qiao J; Zhou J; Guan Y; Li T; Qi X; Luan G
Sci Rep; 2022 Oct; 12(1):18163. PubMed ID: 36307486
[TBL] [Abstract][Full Text] [Related]
12. Significance of BRAF
Mohamed Yusoff AA; Abd Radzak SM; Mohd Khair SZN; Abdullah JM
Exp Oncol; 2021 Jun; 43(2):159-167. PubMed ID: 34190524
[TBL] [Abstract][Full Text] [Related]
13. Combined pleomorphic xanthoastrocytoma-ganglioglioma with BRAF V600E mutation: case report.
Cicuendez M; Martinez-Saez E; Martinez-Ricarte F; Asanza EC; Sahuquillo J
J Neurosurg Pediatr; 2016 Jul; 18(1):53-7. PubMed ID: 27015517
[TBL] [Abstract][Full Text] [Related]
14. Role of diffusion weighted imaging for differentiating cerebral pilocytic astrocytoma and ganglioglioma BRAF V600E-mutant from wild type.
Ramaglia A; Tortora D; Mankad K; Lequin M; Severino M; D'Arco F; Löbel U; Benenati M; de Leng WWJ; De Marco P; Milanaccio C; Rossi A; Morana G
Neuroradiology; 2020 Jan; 62(1):71-80. PubMed ID: 31667545
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and cumulative analysis of clinical properties of BRAF V600E mutations in PLNTY histological samples.
Baumgartner ME; Lang SS; Tucker AM; Madsen PJ; Storm PB; Kennedy BC
Childs Nerv Syst; 2024 May; 40(5):1361-1366. PubMed ID: 38150037
[TBL] [Abstract][Full Text] [Related]
16. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.
Lee D; Cho YH; Kang SY; Yoon N; Sung CO; Suh YL
J Surg Oncol; 2015 Mar; 111(3):359-64. PubMed ID: 25346165
[TBL] [Abstract][Full Text] [Related]
17. Clinical Relevance of BRAF V600E Mutation Status in Brain Tumors with a Focus on a Novel Management Algorithm.
Kowalewski A; Durślewicz J; Zdrenka M; Grzanka D; Szylberg Ł
Target Oncol; 2020 Aug; 15(4):531-540. PubMed ID: 32648041
[TBL] [Abstract][Full Text] [Related]
18. Clinical neuropathology practice news 2-2012: BRAF V600E testing.
Capper D; Berghoff AS; von Deimling A; Preusser M
Clin Neuropathol; 2012; 31(2):64-6. PubMed ID: 22385786
[TBL] [Abstract][Full Text] [Related]
19.
Kakkar A; Majumdar A; Pathak P; Kumar A; Kumari K; Tripathi M; Sharma MC; Suri V; Tandon V; Chandra SP; Sarkar C
Neurol India; 2017; 65(5):1076-1082. PubMed ID: 28879901
[TBL] [Abstract][Full Text] [Related]
20. BRAF alterations in primary brain tumors.
Maraka S; Janku F
Discov Med; 2018 Aug; 26(141):51-60. PubMed ID: 30265855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]